In contrast, down-regulating JMJD3 by siRNA-mediated knockdown, reduced JMJD3 binding and increased H3K27me3 enrichment within the CD11a promoter, which suppressed CD11a expression and reversed the auto-reactivity of T cells in SLE patients. This evidence concerns the gene KDM6B and systemic lupus erythematosus.